ENTITY

Arbutus Biopharma (ABUS US)

2
Analysis
Health Care • United States
Arbutus Biopharma Corporation operates as a biopharmaceutical company. The Company specializes in discovering, developing, and commercializing a portfolio of drug candidates for patients suffering from chronic hepatitis B infection. Arbutus Biopharma serves patients and customers in Canada.
more
Exchange Announcement • 21 Aug 2026 19:53

Current Report (Form 8-K | Period ending 2026-08-21)

Exchange Announcement • 12 Aug 2026 19:31

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 12 Aug 2026 19:31

Current Report (Form 8-K | Period ending 2026-08-12)

Exchange Announcement • 16 Jul 2026 19:31

Current Report (Form 8-K | Period ending 2026-07-15)

Exchange Announcement • 06 Jun 2026 04:05

S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

x